Weekly Docetaxel in the Treatment of Metastatic Breast Cancer

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s3397
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

High Efficacy and Low Toxicity of Weekly Docetaxel Given as First-Line Treatment for Metastatic Breast Cancer

Oncology
MedicineCancer ResearchOncology
2005English

Weekly Epirubicin in the Treatment of Gestational Breast Cancer (GBC)

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Eribulin Mesylate in the Treatment of Metastatic Breast Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1999English

Changing Treatment Paradigms in Metastatic Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2015English

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology
Urology
2008English

Choosing Treatment for Metastatic Breast Cancer.

BMJ
1982English

Vectors for Treatment of Metastatic Breast Cancer

2005English

Weekly Docetaxel for Outpatients With Head and Neck Cancer

Japanese jornal of Head and Neck Cancer
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy